FDA inspects wrong Chinese plant
The linkurl:US Food and Drug Administration;http://www.the-scientist.com/article/display/36885/ admitted yesterday that it never inspected a Chinese facility supplying the active ingredient in heparin, a widely used blood thinner recently implicated in more than 350 adverse reactions and four deaths in US patients. The oversight resulted from a case of mistaken identity, according to a linkurl:story;http://www.washingtonpost.com/wp-dyn/content/article/2008/02/18/AR2008021802315.html?wpisrc=newsl


The Scientist ARCHIVES
Become a Member of
Meet the Author
Bob Grant
From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.View full profile